Ireland - English - HPRA (Health Products Regulatory Authority)

brown & burk ir limited - phenoxymethylpenicillin - powder for oral solution - 250 mg/5ml - beta-lactamase sensitive penicillins; phenoxymethylpenicillin

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

Ireland - English - HPRA (Health Products Regulatory Authority)

morningside healthcare limited - phenoxymethylpenicillin - film coated tablet - 250 milligram - phenoxymethylpenicillin

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - phenoxymethylpenicillin potassium 279mg equivalent to phenoxymethylpenicillin 250 mg (actual formula based on 100% potency); phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg; phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg; phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg - capsule - 250 mg - active: phenoxymethylpenicillin potassium 279mg equivalent to phenoxymethylpenicillin 250 mg (actual formula based on 100% potency) excipient: brilliant blue fcf erythrosine gelatin magnesium stearate opacode white s-1-7085 sunset yellow fcf titanium dioxide active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: capsugel orange op.c027 magnesium stearate active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: capsugel orange op.c027 magnesium stearate active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: gelatin capsule - maroon - mi01429 gelatin capsule - maroon - mi01430 magnesium stearate - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - phenoxymethylpenicillin potassium 28.284 mg/ml equivalent to 25 mg/ml phenoxymethylpenicillin.;  ;   - granules for oral solution - 125 mg/5ml - active: phenoxymethylpenicillin potassium 28.284 mg/ml equivalent to 25 mg/ml phenoxymethylpenicillin.     excipient: orange 175-78-8 orange flavour j1978 10814413 saccharin sodium sodium benzoate sucrose as caster sugar. - treatment of mild to moderately severe infections caused by penicillin-sensitive organisms. the following infections will usually respond to an adequate dosage of penicillin.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - phenoxymethylpenicillin potassium 56.568 mg/ml equivalent to 50 mg/ml phenoxymethylpenicillin;  ;   - granules for oral solution - 250 mg/5ml - active: phenoxymethylpenicillin potassium 56.568 mg/ml equivalent to 50 mg/ml phenoxymethylpenicillin     excipient: orange 175-78-8 orange flavour j1978 10814413 saccharin sodium sodium benzoate sucrose as caster sugar. - treatment of mild to moderately severe infections caused by penicillin-sensitive organisms. the following infections will usually respond to an adequate dosage of penicillin.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - phenoxymethylpenicillin potassium - oral solution - 50mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - phenoxymethylpenicillin, quantity: 500 mg - capsule, hard - excipient ingredients: erythrosine; titanium dioxide; sunset yellow fcf; brilliant blue fcf; magnesium stearate; gelatin; indigo carmine; allura red ac; quinoline yellow aluminium lake; iron oxide black; sd alcohol 3-a - penicilin v potassium is indicated in the treatment of mild to moderately severe infections due to penicillin v sensitive micro-organisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteraemia, pericarditis, meningitis and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed.